Neuroscience Antibodies and Assays Market Share will Witness a YOY Growth Rate of 8.95% in 2023 

The neuroscience antibodies and assays market share is forecast to reach USD 1,837.68 million, after growing at a CAGR of 9.44% during 2023-2027. The increasing incidence of neurological disorders is analyzed to boost the addictions therapeutics market growth. Moreover, increasing number of clinical trials is the major trend enhancing the overall market demand for neuroscience antibodies and assays during the forecast period.   

Get a snapshot on the neuroscience antibodies and assays market analysis: Unlock the Sample Report 

Technavio’s report on: “Neuroscience Antibodies and Assays Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027" covers an in-depth analysis of the following segments of the market. 

Product: 

• Consumables: The neuroscience antibodies and assays market growth by the Consumables segment will be significant during the forecast period.  Factors such as growing significance of neuroscience processes and neurodegenerative diseases research and the wide availability of antibodies, assay kits, and reagents will drive the growth of the consumables segment during the forecast period.

• Instruments

Geography: 

• North America: The increasing demand for the diagnosis of neurological disorders will contribute 46% of market growth by 2027. 

• Europe 

• Asia 

• Rest of World (ROW) 

End-user: 

• Pharmaceutical and biopharmaceutical companies 

• Academic and research institutes 

• Hospital and diagnostic centers

Key Takeaways: 

• The neuroscience antibodies and assays market size will witness a YOY Growth Rate of 8.95% in 2023.  

• The high development cost of neuroscience antibodies will be a major challenge for the neuroscience antibodies and assays market during the forecast period. 

• Major key neuroscience antibodies and assays market players include: Abcam plc, Abnova Corp., ADx NeuroSciences NV, Bio Rad Laboratories Inc., Biosensis Pty Ltd., BMG LABTECH GmbH, Cell Signaling Technology Inc., Chemie Brunschwig AG, Elabscience Biotechnology Inc., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Merck and Co. Inc., NSJ Bioreagents, PerkinElmer Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Siemens AG, and Thermo Fisher Scientific Inc.

• The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the North America, Europe, Asia, and Rest of World (ROW). 

Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth. 

Key data covered in the Neuroscience Antibodies and Assays Market report 

• Precise market size estimation during the forecast period 2023-2027.  

• CAGR of the neuroscience antibodies and assays market forecast during 2023-2027.  

• Market-level data on units, average selling prices, and values of the neuroscience antibodies and assays market share.  

• Prediction of the upcoming trends, drivers, and factors that challenge the growth of the neuroscience antibodies and assays market.  

• Neuroscience antibodies and assays industry growth across North America, Europe, Asia, and Rest of World (ROW).